- Home
- EBMT vs ORGO Comparison
EBMT vs ORGO Comparison
Compare EBMT & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBMT | ORGO |
|---|---|---|
| Founded | 1922 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 166.0M |
| IPO Year | 2009 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EBMT | ORGO |
|---|---|---|
| Price | $20.59 | $1.20 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $24.00 | $2.00 |
| AVG Volume (30 Days) | 20.8K | ★ 589.8K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | 53.23 | ★ 1600.00 |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $5.89 | N/A |
| Revenue Next Year | $3.84 | $37.55 |
| P/E Ratio | $21.17 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $15.80 | $1.22 |
| 52 Week High | $24.66 | $7.08 |
Technical Indicators
Market Signals| Indicator | EBMT | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 30.84 | 27.22 |
| Support Level | $20.00 | N/A |
| Resistance Level | $22.63 | $2.69 |
| Average True Range (ATR) | 0.67 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 22.40 | 3.77 |
Price Performance
Historical ComparisonAbout EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.